Rapid Clone Screening of Biosimilar Candidates Using Microfluidic CE-MS
May. 14, 2024 | 8:00 am PT, 11:00 am ET, 17:00 CET
In TODAY's GEN webinar, our expert speakers, Erin Redman, PhD, and Ruben Cageling, will describe how the ZipChip microfluidic CE-MS technology enables rapid early-stage clone screening for biotherapeutics development.
Endpoints: Critical Preclinical Markers in Neurodegeneration Disease Assays
May. 16, 2024 | 1:00 pm PT, 4:00 pm ET, 22:00 CET
In this GEN webinar, our speaker John Renger, PhD, CSO at Cerevel Therapeutics, discusses preclinical markers used in assays relevant to neurodegenerative disease processes, including the evaluation of autophagy and mitophagy using methods such as immunohistochemistry, western blotting, ELISA-like assays, high content analysis, and other platforms.
Can Organoids Unlock the Pathology of Traumatic Brain Injuries?
May. 17, 2024 | 1:00 pm PT, 4:00 pm ET, 22:00 CET
In this GEN webinar, Justin Ichida, PhD, an expert in stem cell biology and regenerative medicine at the Keck School of Medicine, USC discusses using organoids to clear up the causes of neuronal damage following TBIs and ways of mitigating injury risks.
Unveiling the Potential of Digital Intelligence to Empower Pharmaceutical Companies
May. 20, 2024 | 1:00 pm PT, 4:00 pm ET, 22:00 CET
In this GEN webinar, Storyful CEO Maria Pacheco will showcase several real-time examples that illustrate how access to digital intelligence can be timely, impactful, and agile for marketing communications strategy or PR in the pharmaceutical industry.
Biologics Drug Development Gets an Upgrade with Humanized Animal Models
May. 21, 2024 | 1:00 pm PT, 4:00 pm ET, 22:00 CET
In this GEN webinar, Aaron Rose, PhD, explores how biological therapeutics are reshaping the traditional drug development process and why humanized models are essential for advancing biologics programs.
Fireside Chat: Post-AACR Spatial Biology Trends & Decoding Cancer Insights
May. 22, 2024 | 8:00 am PT, 11:00 am ET, 17:00 CET
Join this keynote discussion on the latest advancements, new norms, emerging trends and breakthrough topics from AACR by our expert panelists, offering clarity on the current landscape, with a deep dive into the latest advancements on how spatial biology is shaping precision medicine and cancer research. Hear expert perspectives on how the global research community has united in an unprecedented collaboration.
Customized mRNA Processing for Improved Therapy Development and Manufacturing
May. 23, 2024 | 1:00 pm PT, 4:00 pm ET, 22:00 CET
In this GEN webinar, Scott Alderucci will discuss ways of leveraging new technologies and experimental design for an optimized, tailored approach to mRNA therapy development.
How Labs Can Prepare for AI-Based Protein Design and Engineering
May. 28, 2024 | 1:00 pm PT, 4:00 pm ET, 22:00 CET
In this timely GEN webinar, Stef van Grieken and Prem Mohanty will discuss how the success of AI / ML technologies is tied to data quality and share specific approaches for generating clean lab data to train models faster.
Strategies for Determining Critical Quality Attributes of Nucleic Acid Therapeutics and Their Carriers
Jun. 06, 2024 | 1:00 pm PT, 4:00 pm ET, 22:00 CET
In this GEN webinar, our expert speaker Oliver Höcker, PhD, will discuss the advantages and limitations of current analytical techniques for determining the CQAs of NA therapeutics using examples from different NA classes.
Using Multiplexed Multi-Omics to Study Spatial Heterogeneity in Ovarian Cancer
Jun. 13, 2024 | 1:00 pm PT, 4:00 pm ET, 22:00 CET
In this GEN webinar,